[Abstract] [Full Text PDF] (in Japanese / 2132KB) [Members Only And Two Factor Auth.]

J.Jpn. Surg. Soc.. 84(9): 800-803, 1983


Report on the annual meeting

HETEROGENEITY IN DRUG SENSITIVITY OF HUMAN TUMORS IN THE HUMAN TUMOR COLONY-FORMING ASSAY

*) The 2nd Department of Surgery, Fukui Medical College, Fukui, Japan
**) The 2nd Department of Surgery, Kyoto University, Kyoto, Japan
***) Department of Urology, Kyoto University, Kyoto, Japan

Nobuhiko Tanigawa*), Yoshifumi Mizuno**), Kazuo Honda**), Takayuki Hashimura***), Kisaku Satomura**), Yorinori Hikasa**)

The human tumor colony-forming assay was used to compare chemosensitivity among tumor cells within a primary tumor, between primary tumor and its metastasis, and between different metastases.
The results indicate that the reported discrepancies of in vitro and in vivo results in clinical trials with TCFA for predicting of resistance or sensitivity to cytosatic drugs may be due to therapeutic heterogeneity among tumor colony-forming units within a primary tumors and between primary tumor and metastases, and that the results from a metastatic lesion may have more profound implications in planning treatment of other metastatic lesions of the same patient.


<< To previous pageTo next page >>

To read the PDF file you will need Adobe Reader installed on your computer.